Mr Jørgensen is currently CEO and President of Biotage AB. He holds a BA in Finance and Administration from Copenhagen Business School. He has previously been CEO of Dako AS, heading this global supplier of research reagents and diagnostic`s between 1989 and 1999. Other positions Mr Jørgensen has held include CEO for Karo Bio and CEO for Affibody AB. He is also Chairman of the board for Chreto A/S.
Haematology